We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
Discover 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies.
Maria Dimitrova shares her career journey from public sector roles working with the SMC and SHTC to joining Mtech Access as a Consultant supporting our Pharma and Medtech clients with HTA submissions.
© 2024 Mtech Access. All rights reserved. Privacy policy. Carbon Reduction Plan. Cookie Settings. Sitemap